Allograft tolerance without the need for systemic immune suppression
AssigneeSinai Health System
InventorsAndras Nagy, Jeffrey Harding, Kristina Nagy
Life of this patent
Estimating the term…
Loading patent…
AssigneeSinai Health System
InventorsAndras Nagy, Jeffrey Harding, Kristina Nagy
Estimating the term…
A cell genetically modified to comprise at least one mechanism for providing a local immunosuppression at a transplant site when transplanted in an allogeneic host is, and methods for making and using the same is provided. The cell comprises a set of transgenes, each transgene encoding a gene product that is cytoplasmic, membrane bound, or local acting, and whose function is one or more of: to mitigate antigen presenting cell activation and function; to mitigate graft attacking leukocyte activity or cytolytic function; to mitigate macrophage cytolytic function and phagocytosis of allograft cells; to induce apoptosis in graft attacking leukocytes; to mitigate local inflammatory proteins; and to protect against leukocyte-mediated apoptosis.
-192. (canceled)
A cell genetically modified to comprise transgenes comprising:
A method for reducing an immune response of a subject to an allogeneic cell, the method comprising:
Dependencies are inferred from the claim text.